Anysis
Platelet Function Test
The Anysis system test provides assessment for inherited, acquired, or drug-induced platelet dysfunction.
Through in-vivo vascular mimicking microfluidics, the system measures a realistic primary hemostasis associated with platelet function.
-
Anysis C/ADP test, Anysis-C/Epinephrine test
-
Screens platelet function for impaired primary hemostasis, such as von Willebrand disease
-
Provides high sensitivity for congenital platelet dysfunction, such as Glanzmann thrombasthenia
-
Anysis-Aspirin test, Anysis-P2Y12 test
-
Assesses platelet dysfunction caused by Aspirin
-
Detects platelet dysfunction caused by P2Y12-receptor inhibitors
-
Anysis-SIPA
-
Assesses Shear-Induced Platelet Activation and Aggregation
Upstream Activation - Downstream Adhesion
Activation
Adhesion
Aggregation
Occlusion
Detection
Activation occurs during the upstream phase whereas the stirrer spins around inside the chamber where blood flows through (ECM). After the activation, the blood flows through the microfluidic tubes passing through microbeads when adhesion occurs and followed by the aggregation of the platelets. When aggregation occurs inside the microfluidic tubes, it will naturally block the inner passage of the tube which will end in occlusion. Measurement of how far the blood has migrated is our result and can be diagnosed - detection.
